Literature DB >> 7609041

A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells.

E J Verschoor1, L A Boven, H Blaak, A L van Vliet, M C Horzinek, A de Ronde.   

Abstract

Feline immunodeficiency virus (FIV) isolates differ in the ability to replicate in Crandell feline kidney (CRFK) cells. The difference in tropism between two variants of the Dutch isolate FIV-UT113 was studied by using molecular clones which contained the envelope genes of the variants in a background of the FIV-14 Petaluma sequence. Virus produced from clone pPET-113Th replicated in thymocytes, whereas virus from pPET-113Cr propagated in both thymocytes and CRFK cells, thereby reflecting the phenotypes of the parental variants. Exchange of envelope gene fragments showed that a 464-bp surface protein (SU)-encoding fragment encompassing the third variable region (V3) determines CRFK cell tropism. Sequence analysis of the exchanged fragments demonstrated two amino acid changes that led to an increase of the overall charge of the V3 domain: a G-->R transition at position 397 and a E-->K change at position 407. Mutational analysis of these residues revealed that the E-->K shift was responsible for the change in tropism, while the G-->R mutation improved the replication kinetics in CRFK cells. Mapping of a tropism determinant for FIV to a region which is also a major neutralization domain is reminiscent of human immunodeficiency virus type 1, in which a similar colocation was found.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609041      PMCID: PMC189284          DOI: 10.1128/JVI.69.8.4752-4757.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Comparison of biological properties of feline immunodeficiency virus isolates using recombinant chimeric viruses.

Authors:  M Kohmoto; T Miyazawa; K Tomonaga; Y Kawaguchi; T Mori; Y Tohya; C Kai; T Mikami
Journal:  J Gen Virol       Date:  1994-08       Impact factor: 3.891

2.  In vivo lymphocyte tropism of feline immunodeficiency virus.

Authors:  R V English; C M Johnson; D H Gebhard; M B Tompkins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

3.  A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus.

Authors:  T Shioda; S Oka; S Ida; K Nokihara; H Toriyoshi; S Mori; Y Takebe; S Kimura; K Shimada; Y Nagai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Authors:  F Baldinotti; D Matteucci; P Mazzetti; C Giannelli; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line.

Authors:  R D Harrington; A P Geballe
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope.

Authors:  S Lombardi; C Garzelli; C La Rosa; L Zaccaro; S Specter; G Malvaldi; F Tozzini; F Esposito; M Bendinelli
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9.

Authors:  B J Willett; M J Hosie; O Jarrett; J C Neil
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

9.  Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain.

Authors:  A de Ronde; J G Stam; P Boers; H Langedijk; R Meloen; W Hesselink; L C Keldermans; A van Vliet; E J Verschoor; M C Horzinek
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

10.  Post-translational processing of the feline immunodeficiency virus envelope precursor protein.

Authors:  E J Verschoor; E G Hulskotte; J Ederveen; M J Koolen; M C Horzinek; P J Rottier
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

View more
  39 in total

1.  Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.

Authors:  Mariko Kohmoto; Yasuhiro Ikeda; Eiji Sato; Yorihiro Nishimura; Yasuo Inoshima; Masayuki Shimojima; Yukinobu Tohya; Takeshi Mikami; Takayuki Miyazawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

2.  Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats.

Authors:  Chengming Wang; Calvin M Johnson; Sudhir K Ahluwalia; Erfan Chowdhury; Yihang Li; Dongya Gao; Anil Poudel; K Shamsur Rahman; Bernhard Kaltenboeck
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

3.  CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectors.

Authors:  J G Baumann; W H Günzburg; B Salmons
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.

Authors:  D L Lerner; J H Elder
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Molecular characterization of feline immunodeficiency virus genome obtained directly from organs of a naturally infected cat with marked neurological symptoms and encephalitis.

Authors:  Y Nishimura; S Nakamura; N Goto; T Hasegawa; H Pang; Y Goto; H Kato; H Y Youn; Y Endo; T Mizuno; Y Momoi; K Ohno; T Watari; H Tsujimoto; A Hasegawa
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.

Authors:  Qiong-Ying Hu; Elizabeth Fink; John H Elder
Journal:  Retrovirology (Auckl)       Date:  2012-07-11

Review 8.  Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.

Authors:  Brian J Willett; Margaret J Hosie
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

9.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.

Authors:  Sean P Troth; Alan D Dean; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.